Pharmaceutical giant Pfizer (PFE) has been through a rough spot in 2025, joining the rest of the stock market as President ...

Stocks in Focus. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other stocks ...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...

Pfizer stock shows strong potential with updates on danuglipron, robust cost controls, and attractive valuations. Learn more ...

Large, unusual trading volume in Pfizer Inc. (PFE) put options is accruing today, signaling a bearish outlook by ...

Pfizer’s PFE stock hit a new 52-week low of $20.92 on Wednesday but recovered thereafter and closed at $22.49 Though the ...

In a report released today, Terence Flynn from Morgan Stanley maintained a Hold rating on Pfizer (PFE – Research Report), with a price target ...

Now, after seeing their request for the borough to leave the scheme rejected, Oldham’s Liberal Democrat group leader Howard ...

A council's bid to back out of a controversial plan to build thousands of new homes across Greater Manchester has been ...

Political leaders in Oldham have offered mixed reactions to the government's rejection of a request to withdraw from the Places for Everyone ...

We recently published a list of 11 Best Innovative Stocks to Buy According to Analysts. In this article, we are going to take a look at where Pfizer Inc.

The local authority’s request to withdraw from Greater Manchester’s Places for Everyone spatial framework has been stymied by housing minister Matthew Pennycook.